For-Robin, Inc.
PrivateLast Round
Grant
Mar 18, 2019
Total Funding Raised
$5.87M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
For-Robin, Inc. operates in Healthcare & Life Sciences and is based in Williamsville, New York. Its latest recorded funding round was a Grant round in March 2019.
For-Robin, Inc. is a biotechnology company that develops immunotherapies for breast and lung cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
For-Robin, Inc. Comparables
Compare For-Robin, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adecto Pharmaceuticals | 84% | |
| GlycoMantra | 78% | |
| Tacalyx | 78% |
For institutional investors. Book with your work email.
For-Robin, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2019 | ||||
| Grant | Jul 1, 2013 | ||||
| Grant | Jul 1, 2013 | ||||
| Grant | May 1, 2013 |
For institutional investors. Book with your work email.
For-Robin, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Bruce Holm Memorial Catalyst Fund | Grant |
| University at Buffalo Center for Advanced Technology in Big Data and Health Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 259% MoM, reaching 1.7K.
- Jul 26, 2026
Monthly visitors grew 62% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
For-Robin, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about For-Robin, Inc.'s valuation, stock price, and market status.
Is For-Robin, Inc. a public or private company?
For-Robin, Inc. is a private company.
What is the current stock price of For-Robin, Inc.?
For-Robin, Inc. is a private company, so its shares have no public market price. Caplight tracks For-Robin, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is For-Robin, Inc. worth (valuation)?
Valuation information for For-Robin, Inc. is not publicly available.
Can I buy For-Robin, Inc. stock?
For-Robin, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was For-Robin, Inc.'s last funding round?
For-Robin, Inc.'s most recent funding round was Grant on March 18, 2019.
Who are the main investors in For-Robin, Inc.?
Key investors in For-Robin, Inc. include National Cancer Institute, NIH RADx, Bruce Holm Memorial Catalyst Fund, University at Buffalo Center for Advanced Technology in Big Data and Health Sciences.
Will For-Robin, Inc. IPO soon?
No public IPO plans have been announced for For-Robin, Inc..
How can I track For-Robin, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in For-Robin, Inc.'s shares on secondary markets.